{"id":51,"date":"2023-02-28T16:02:33","date_gmt":"2023-02-28T14:02:33","guid":{"rendered":"https:\/\/webs.uab.cat\/dmrqb\/?page_id=51"},"modified":"2026-07-06T12:54:29","modified_gmt":"2026-07-06T10:54:29","slug":"inici","status":"publish","type":"page","link":"https:\/\/webs.uab.cat\/molbiomed\/","title":{"rendered":"Benvinguts a la p\u00e0gina web del nostre grup de recerca!"},"content":{"rendered":"\n
\n
\n
\n
<\/div>\n\n\n\n
\n
\"\"<\/figure>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

Qu\u00e8 es fa al nostre grup?<\/h2>\n\n\n\n
\n
\n
\n

Fotoqu\u00edmica<\/strong><\/h2>\n\n\n\n

La utilitat dels fotointerruptors com a f\u00e0rmacs \u00e9s gegant amb la Qu\u00edmica Qu\u00e0ntica estem intentar entedre com funcionen i com millorar-los<\/p>\n<\/div>\n\n\n\n

\n

Disseny de Prote\u00efnes<\/h2>\n\n\n\n

La modificaci\u00f3 d’enzims \u00e9s una de les eines m\u00e9s potents per sintetitzar compostos espec\u00edfics<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

\n
\n
\n

Disseny de F\u00e0rmacs<\/h2>\n\n\n\n

Estem intentant redissenyar f\u00e0rmacs per la inhibici\u00f3 de la inflamaci\u00f3 <\/p>\n<\/div>\n\n\n\n

\n

Efectes Al\u00b7lost\u00e8rics<\/h2>\n\n\n\n

De vegades la activitat dels enzims dep\u00e8n del moviment de diversos dominis de la estructura de la prote\u00efna, per entendre com funciona, s’han d’estudiar aquest moviments<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

\n
Projectes<\/a><\/div>\n\n\n\n
Publicacions<\/a><\/div>\n<\/div>\n\n\n\n

\u00daltimes publicacions <\/h2>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n

Omega-3 DHA as a blank canvas: A molecular approximation to how lipid mediators modulate LGR6 in inflammation resolution<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Llegeix M\u00e9s<\/a><\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Photoswitchable COX-2-Selective Inhibitors as Light-Regulated Anti-Inflammatory Agents<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Llegeix M\u00e9s<\/a><\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Exploring allosteric properties of mammalian ALOX15: octyl (N<\/em>-(4-(benzofuran-2-yl)-2-methoxyphenyl)sulfamoyl)- and octyl (N<\/em>-(4-(1H<\/em>-indol-2-yl)-2-methoxyphenyl)sulfamoyl)carbamates as ALOX inhibitors<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Llegeix M\u00e9s<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n

\u00daltimes not\u00edcies<\/h2>\n\n\n\n
\n
\n

2 de juliol del 202<\/em>6<\/p>\n\n\n\n

L’\u00c0ngels \u00e9s convidada a l’ESPA2026 com a ponent<\/h1>\n\n\n\n

A la seva presentaci\u00f3 va poder presentar el treball titulat: “Allosteric regulation by 12-LOX of two competitive pathways in maresin-1 biosynthesis: epoxidation versus oxygenation”<\/p>\n\n\n\n

\"\"
Universidad de Salamanca, Salamanca<\/figcaption><\/figure>\n<\/div>\n\n\n\n
\n

1 de juliol de 2026<\/em><\/p>\n\n\n\n

El Pedro assiteix al 10EWLM<\/h1>\n\n\n\n

El seu treball “In Silico<\/em> Investigation of Human ALOX12 Allosteric Regulation: Competitive Catalytic Pathways of 14S-HpDHA” guanya el premi a millor p\u00f2ster. <\/p>\n\n\n\n

\"\"
Institut Pasteur, Par\u00eds, Fran\u00e7a<\/figcaption><\/figure>\n\n\n\n
\"\"
Entrega de premis a millor p\u00f2ster<\/figcaption><\/figure>\n<\/div>\n\n\n\n
\n

8 <\/em>d’abril de 2026<\/em><\/p>\n\n\n\n

L’\u00c1lex i l’Alba assisteixen al 5th International Symposium on Photopharmacology<\/em> a S\u00e8te, Fran\u00e7a<\/h1>\n\n\n\n

L’\u00c1lex i l’Alba han presentat al 5th<\/em> International Symposium on Photopharmacology<\/em> un poster del seu \u00faltim treball.<\/p>\n\n\n\n

\"\"
\u00c1lex P\u00e9rez S\u00e1nchez, Domaine du Lazaret a S\u00e8te<\/figcaption><\/figure>\n\n\n\n
\"\"
Alba Villar-Yanez, Domaine du Lazaret a S\u00e8te<\/figcaption><\/figure>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Qu\u00e8 es fa al nostre grup? Fotoqu\u00edmica La utilitat dels fotointerruptors com a f\u00e0rmacs \u00e9s gegant amb la Qu\u00edmica Qu\u00e0ntica estem intentar entedre com funcionen i com millorar-los Disseny de Prote\u00efnes La modificaci\u00f3 d’enzims \u00e9s una de les eines m\u00e9s potents per sintetitzar compostos espec\u00edfics Disseny de F\u00e0rmacs Estem intentant redissenyar f\u00e0rmacs per la inhibici\u00f3 […]<\/p>\n","protected":false},"author":2580,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-51","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/webs.uab.cat\/molbiomed\/wp-json\/wp\/v2\/pages\/51","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/webs.uab.cat\/molbiomed\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/webs.uab.cat\/molbiomed\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/webs.uab.cat\/molbiomed\/wp-json\/wp\/v2\/users\/2580"}],"replies":[{"embeddable":true,"href":"https:\/\/webs.uab.cat\/molbiomed\/wp-json\/wp\/v2\/comments?post=51"}],"version-history":[{"count":77,"href":"https:\/\/webs.uab.cat\/molbiomed\/wp-json\/wp\/v2\/pages\/51\/revisions"}],"predecessor-version":[{"id":3040,"href":"https:\/\/webs.uab.cat\/molbiomed\/wp-json\/wp\/v2\/pages\/51\/revisions\/3040"}],"wp:attachment":[{"href":"https:\/\/webs.uab.cat\/molbiomed\/wp-json\/wp\/v2\/media?parent=51"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}